Skip to content
value.today

Bio Key International Inc.

Bio Key International Inc. is listed today as BIO-Key International, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 5 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Bio Key International Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2019$3 MPrivate placement after listing$2 to $10 million

Bio Key International Inc.: Private sale, Jul 2019

Investors in this round

1 investor had bought by the notice of Jul 25, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$178,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cecilia K. Welch · Executive Officer
  • Michael W. DePasquale · Executive Officer, Director
  • Mira K. LaCous · Executive Officer
  • Fabian E. Shin · Director
  • Pieter E. Knook · Director
  • Robert J. Michel · Director
  • Thomas E. Bush · Director
  • Thomas E. Gilley · Director
  • Wong Kwok W. Fong · Director
  • Yan E. Jianhui · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · broker-dealer Maxim Group LLC (CRD 120708) · New York, New YorkSold in NY

Signed by Cecilia Welch, Cfo. Newest notice filed Jul 25, 2019. Read the notice at the SEC.

debt, optionsSEC
Nov 2014$1 MPrivate placement after listingUnder $2 million

Bio Key International Inc.: Private sale, Nov 2014

Investors in this round

20 investors had bought by the notice of Nov 19, 2014: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cecilia E. Welch · Executive Officer
  • Michael W. DePasquale · Executive Officer, Director
  • Mira K. LaCous · Executive Officer
  • Renat K. Zhdanov · Executive Officer
  • Scott K. Mahnken · Executive Officer
  • Barbara P. Rivera · Director
  • Charles P. Romeo · Director
  • John P. Schoenherr · Director
  • Thomas E. Bush, III · Director
  • Thomas E. Gilley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cecilia Welch, Chief Financial Officer. Newest notice filed Nov 19, 2014. Read the notice at the SEC.

equity, optionsSEC
Oct 2013$4 MPrivate placement after listing$2 to $10 million

Bio Key International Inc.: Private sale, Oct 2013

Investors in this round

47 investors had bought by the notice of Nov 8, 2013: 47 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
$100,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$295,768
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cecilia Welch · Executive Officer
  • Renat Zhdanov · Executive Officer
  • Scott Mahnken · Executive Officer
  • Charles Romeo · Director
  • John Schoenherr · Director
  • Michael DePasquale · Director
  • Thomas Colatosti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Dougherty & Company LLC (CRD 7477) · Minneapolis, MinnesotaSold in CA, CO, IL, MA, MD, NJ, NY, PA, SD, WI

Signed by Cecilia Welch, Chief Financial Officer. Newest notice filed Nov 8, 2013. Read the notice at the SEC.

equity, optionsSEC
Jul 2013$1 MPrivate placement after listingUnder $2 million

Bio Key International Inc.: Private sale, Jul 2013

Investors in this round

15 investors had bought by the notice of Aug 6, 2013: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cecilia C. Welch · Executive Officer
  • Michael W. DePasquale · Executive Officer, Director
  • Mira K LaCous · Executive Officer
  • Renat K Zhdanov · Executive Officer
  • Scott K Mahnken · Executive Officer
  • Charles P. Romeo · Director
  • Jeffrey J. May · Director
  • John P. Schoenherr · Director
  • Thomas J. Colatosti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cecilia C. Welch, Chief Financial Officer. Newest notice filed Aug 6, 2013. Read the notice at the SEC.

equity, optionsSEC
Dec 2009$2 MIssued in a merger or acquisition$2 to $10 million

Bio Key International Inc.: Private sale, Dec 2009

Investors in this round

1 investor had bought by the notice of Dec 23, 2009: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth S. Souza · Executive Officer
  • Michael W. DePasquale · Executive Officer, Director
  • Randy P. Fodero · Executive Officer
  • Thomas Colatosti · Executive Officer, Director
  • Charles P. Romeo · Director
  • Jeffrey J. May · Director
  • John P. Schoenherr · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas J. Colatosti, Ceo. Newest notice filed Dec 23, 2009. Read the notice at the SEC.

optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company BIO-Key International, Inc., its revenue in fiscal 2025 came from these product and service lines: License $3.42 million (58%), Hardware $1.34 million (23%).

    Annual report (SEC XBRL) · Dec 2025

  • Bio Key International Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2019).

    SEC Form D · Jul 2019

  • The industry group it chose in its notices: Other.

    SEC Form D · Jul 2019

Products and services#

No products or services of Bio Key International Inc. are on record.

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in Bio Key International Inc.
InvestorKindAmountRoundRoleSource
Fong Wong KwokPersonnot statednot statedHeld Series A-1 preferred stock, director (Form 3, 2015)SEC Form 3
Micron Technology Development LtdCompanynot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Largest shareholders today

Institutions holding BIO-Key International, Inc. shares, as of Sep 30, 2026.

As of Sep 30, 2026

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bio Key International Inc.
NameRoleNamed in
Cecilia K. WelchExecutive officerJul 2019
Michael W. DePasqualeExecutive officerJul 2019
Mira K. LaCousExecutive officerJul 2019
Cecilia E. WelchExecutive officerNov 2014
Renat K. ZhdanovExecutive officerNov 2014
Scott K. MahnkenExecutive officerNov 2014
Cecilia WelchExecutive officerNov 2013
Renat ZhdanovExecutive officerNov 2013
Scott MahnkenExecutive officerNov 2013
Cecilia C. WelchExecutive officerAug 2013
Mira K LaCousExecutive officerAug 2013
Renat K ZhdanovExecutive officerAug 2013
Scott K MahnkenExecutive officerAug 2013
Kenneth S. SouzaExecutive officerDec 2009
Randy P. FoderoExecutive officerDec 2009
Thomas ColatostiExecutive officerDec 2009
Fabian E. ShinDirectorJul 2019
Michael W. DePasqualeDirectorJul 2019
Pieter E. KnookDirectorJul 2019
Robert J. MichelDirectorJul 2019
Thomas E. BushDirectorJul 2019
Thomas E. GilleyDirectorJul 2019
Wong Kwok W. FongDirectorJul 2019
Yan E. JianhuiDirectorJul 2019
Barbara P. RiveraDirectorNov 2014
Charles P. RomeoDirectorNov 2014
John P. SchoenherrDirectorNov 2014
Thomas E. Bush, IIIDirectorNov 2014
Charles RomeoDirectorNov 2013
John SchoenherrDirectorNov 2013
Michael DePasqualeDirectorNov 2013
Thomas ColatostiDirectorNov 2013
Jeffrey J. MayDirectorAug 2013
Thomas J. ColatostiDirectorAug 2013

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.